Vol. 42.S2 July 2016 | Medicina de Familia. SEMERGEN

ISSN: 1138-3593

Indexed in:

Web of Science, MedLine/PubMed y SCOPUS, Emerging Sources Citation Index (ESCI)

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

0.9

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.4

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.22

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.284

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 42. Issue S2.

Papel de los alfabloqueantes en el tratamiento de los síntomas del tracto urinario inferior/hiperplasia benigna de próstata: ¿son todos iguales? Silodosina en la “vida real”

Pages 1-9 (July 2016)

Papel de los alfabloqueantes en el tratamiento de los síntomas del tracto urinario inferior/hiperplasia benigna de próstata: ¿son todos iguales? Silodosina en la “vida real”

A. Alcántara Montero

Semergen. 2016;42 Supl 2:1-9

Full text access

Open Article

Publish in

Medicina de Familia. SEMERGEN

Medicina de Familia. SEMERGEN follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter